ImmunityBio, Inc.IBRXNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-264.43M
↓ 20% below average
Average (9y)
$-220.77M
Historical baseline
Range
High:$-56.85M
Low:$-478.66M
CAGR
+1.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-264.43M | +44.8% |
| 2023 | $-478.66M | -36.0% |
| 2022 | $-351.88M | -9.7% |
| 2021 | $-320.75M | -57.1% |
| 2020 | $-204.22M | -259.2% |
| 2019 | $-56.85M | +34.5% |
| 2018 | $-86.74M | +4.4% |
| 2017 | $-90.73M | +22.9% |
| 2016 | $-117.71M | +50.1% |
| 2015 | $-235.71M | - |